Appointment of Professor Akiko Iwasaki to Scientific Advisory Board
Retrieved on:
Friday, December 18, 2020
Brings extensive experience in Immunology within the field of infectious diseases, most recently in COVID-19
Key Points:
- Brings extensive experience in Immunology within the field of infectious diseases, most recently in COVID-19
LONDON & BOSTON 4BIO Capital (4BIO or the Group), an international venture capital firm focused solely on the advanced therapies sector, announces the appointment of Professor Akiko Iwasaki to its Scientific Advisory Board (SAB). - Professor Iwasaki has made significant contributions towards understanding innate and adaptive immunity.
- Dmitry Kuzmin, Managing Partner at 4BIO Capital, said: We are delighted to welcome Professor Iwasaki to 4BIOs Scientific Advisory Board.
- Professor Akiko Iwasaki said: I am excited to join 4BIOs Scientific Advisory Board.